Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP); Meeting, 13413-13414 [2011-5626]

Download as PDF 13413 Federal Register / Vol. 76, No. 48 / Friday, March 11, 2011 / Notices EXHIBIT 1— ESTIMATED ANNUALIZED BURDEN HOURS Maximum No. of respondents Interview type No. of responses per respondent Maximum hours per response Total burden hours Screening Questionnaire ......................................................... Needs Assessment .................................................................. Usability Testing ...................................................................... Discussion Groups ................................................................... 120 18 18 64 1 1 1 1 3/60 1.0 1.5 1.5 6 18 27 96 Total .................................................................................. 120 na na 147 EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN Maximum No. of respondents Interview type Total burden hours Average hourly wage rate * Total cost burden Screening Questionnaire ......................................................... Needs Assessment .................................................................. Usability Testing ...................................................................... Discussion Groups ................................................................... 120 18 18 64 6 18 27 96 $50.71 50.71 50.71 50.71 $304 913 1,369 4,868 Total .................................................................................. 120 147 NA 7,454 * The hourly wage for the participants across the four data collections (screening questionnaire, needs assessment interview, usability testing interviews, and discussion group interviews) is based upon the mean of the average hourly wages for Social science research assistants (19– 4061; $19.39 per hour); Postsecondary Health Specialties Teachers (25–1071; $53.88 per hour); Management analysts (13–1111; $40.70 per hour); Computer and Information Systems Managers (11–3021; $58.00 per hour); Family and General Practitioners Teachers (29–1060; $81.03 per hour); Pharmacists (29–1051; $51.27 per hour). May 2009 National Occupational Employment and Wage Estimates, United States, U.S. Bureau of Labor Statistics Division of Occupational Employment Statistics https://www.bls.gov/oes/current/oes_nat.htm#29–0000. Estimated Annual Costs to the Federal Government The estimated total cost to the Federal Government for this project is $411,641.00 over a two-year period from September 8, 2010 to September 7, 2012. The estimated average annual cost is $205,821. Exhibit 3 provides a breakdown of the estimated total and average annual costs by category. EXHIBIT 3—ESTIMATED TOTAL AND ANNUAL COST * TO THE FEDERAL GOVERNMENT Cost component Total cost Annualized cost Project Management and Coordination Activities ....................................................................................... Evaluation Plan and Protocol Development ................................................................................................ OMB Submission Package .......................................................................................................................... Conduct Evaluation ** .................................................................................................................................. Data Analysis, Report and Briefing ............................................................................................................. Documentation and 508 Compliance .......................................................................................................... $58,140 44,908 12,362 159,991 118,081 18,159 $29,070 22,454 6,181 79,996 59,041 9,080 Total ...................................................................................................................................................... 411,641 205,821 * Costs are fully loaded including overhead, G&A and fees. ** These activities include the data collections described in this submission. srobinson on DSKHWCL6B1PROD with NOTICES Request for Comments In accordance with the Paperwork Reduction Act, comments on AHRQ’s information collection are requested with regard to any of the following: (a) Whether the proposed collection of information is necessary for the proper performance of AHRQ healthcare research and healthcare information dissemination functions, including whether the information will have practical utility; (b) the accuracy of AHRQ’s estimate of burden (including hours and costs) of the proposed collection(s) of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information upon the VerDate Mar<15>2010 17:08 Mar 10, 2011 Jkt 223001 respondents, including the use of automated collection techniques or other forms of information technology. Comments submitted in response to this notice will be summarized and included in the Agency’s subsequent request for OMB approval of the proposed information collection. All comments will become a matter of public record. Dated: March 2, 2011. Carolyn M. Clancy, Director. [FR Doc. 2011–5401 Filed 3–10–11; 8:45 am] BILLING CODE 4160–90–M PO 00000 Frm 00076 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP); Meeting Studies at the Animal-Human Interface of Influenza and Other Zoonotic Diseases in Vietnam, Funding Opportunity Announcement (FOA) IP11–005; The Incidence and Etiology of Influenza-Associated CommunityAcquired Pneumonia in Hospitalized Persons Study, FOA IP11–011; Spectrum of Respiratory Pathogens in Acute Respiratory Tract Infection E:\FR\FM\11MRN1.SGM 11MRN1 13414 Federal Register / Vol. 76, No. 48 / Friday, March 11, 2011 / Notices Among Children and Adults in India, FOA IP11–012; Influenza Vaccine Efficacy in Tropical and Developing Countries, FOA IP11–013; and Influenza and Other Respiratory Diseases in Southern Hemisphere, FOA IP11–014; initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: DEPARTMENT OF HEALTH AND HUMAN SERVICES Time and Date: 8 a.m.–5 p. m., May 12, 2011 (Closed). Place: Sheraton Gateway Hotel Atlanta Airport, 1900 Sullivan Road, Atlanta, Georgia 30337, Telephone: (770) 997–1100. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Studies at the Animal-Human Interface of Influenza and Other Zoonotic Diseases in Vietnam, FOA IP11–005; The Incidence and Etiology of InfluenzaAssociated Community-Acquired Pneumonia in Hospitalized Persons Study, FOA IP11– 011; Spectrum of Respiratory Pathogens in Acute Respiratory Tract Infection Among Children and Adults in India, FOA IP11–012; Influenza Vaccine Efficacy in Tropical and Developing Countries, FOA IP11–013; and Influenza and Other Respiratory Diseases in Southern Hemisphere, FOA IP11–014, initial review.’’ Contact Person for More Information: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road, NE., Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 498–2293. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Dated: March 7, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. srobinson on DSKHWCL6B1PROD with NOTICES [FR Doc. 2011–5626 Filed 3–10–11; 8:45 am] BILLING CODE 4163–18–P Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Continuation of the National Mesothelioma Virtual Bank for Translational Research, Program Announcement PAR 11–002, Initial Review Time and Date: 2 p.m.–4 p.m., April 5, 2011 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of ‘‘Continuation of the National Mesothelioma Virtual Bank for Translational Research, PAR 11–002.’’ Contact Person for More Information: M. Chris Langub, Ph.D., Scientific Review Officer, CDC, 1600 Clifton Road, NE., Mailstop E74, Atlanta, Georgia 30333, Telephone: (404) 498–2543. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: March 3, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2011–5630 Filed 3–10–11; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Pilot Longitudinal Data Collection To Inform Public Health—Fragile X Syndrome, DD11–007, Initial Review Notice of Cancellation: This notice was published in the Federal Register on December 17, 2010, Volume 75, Number 242, page 78997. VerDate Mar<15>2010 17:08 Mar 10, 2011 Jkt 223001 PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 This SEP previously scheduled to convene on April 15, 2011, is cancelled in its entirety. Contact Person for More Information: Donald Blackman, Ph.D., Scientific Review Officer, CDC, National Center for Chronic Disease Prevention and Health Promotion, Office of the Director, Extramural Research Program Office, 4770 Buford Highway, NE., Mailstop K– 92, Atlanta, Georgia 30341, Telephone: (770) 488–3023, E-mail: DBY7@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: March 4, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2011–5628 Filed 3–10–11; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Evaluation of the Impact of Work or School Exclusion Criteria on the Spread of Influenza and Influenza-Like-Illness (U01), Funding Opportunity Number (FOA) CK11–007, Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 8 a.m.–5 p.m., May 2, 2011 (Closed). Place: Sheraton Gateway Hotel Atlanta Airport, 1900 Sullivan Road, Atlanta, Georgia 30337, Telephone: (770) 997–1100. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Evaluation of the Impact of Work or School Exclusion Criteria on the Spread of Influenza and Influenza-like-Illness (U01), FOA CK11–007.’’ Contact Person for More Information: Dr. Amy Yang, Scientific Review Officer, CDC, 1600 Clifton Road, NE., Mailstop E60, E:\FR\FM\11MRN1.SGM 11MRN1

Agencies

[Federal Register Volume 76, Number 48 (Friday, March 11, 2011)]
[Notices]
[Pages 13413-13414]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-5626]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP); Meeting

    Studies at the Animal-Human Interface of Influenza and Other 
Zoonotic Diseases in Vietnam, Funding Opportunity Announcement (FOA) 
IP11-005; The Incidence and Etiology of Influenza-Associated Community-
Acquired Pneumonia in Hospitalized Persons Study, FOA IP11-011; 
Spectrum of Respiratory Pathogens in Acute Respiratory Tract Infection

[[Page 13414]]

Among Children and Adults in India, FOA IP11-012; Influenza Vaccine 
Efficacy in Tropical and Developing Countries, FOA IP11-013; and 
Influenza and Other Respiratory Diseases in Southern Hemisphere, FOA 
IP11-014; initial review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date: 8 a.m.-5 p. m., May 12, 2011 (Closed).
    Place: Sheraton Gateway Hotel Atlanta Airport, 1900 Sullivan 
Road, Atlanta, Georgia 30337, Telephone: (770) 997-1100.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``Studies at the Animal-Human Interface of Influenza and 
Other Zoonotic Diseases in Vietnam, FOA IP11-005; The Incidence and 
Etiology of Influenza-Associated Community-Acquired Pneumonia in 
Hospitalized Persons Study, FOA IP11-011; Spectrum of Respiratory 
Pathogens in Acute Respiratory Tract Infection Among Children and 
Adults in India, FOA IP11-012; Influenza Vaccine Efficacy in 
Tropical and Developing Countries, FOA IP11-013; and Influenza and 
Other Respiratory Diseases in Southern Hemisphere, FOA IP11-014, 
initial review.''
    Contact Person for More Information: Gregory Anderson, M.S., 
M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road, NE., 
Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 498-2293. The 
Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: March 7, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2011-5626 Filed 3-10-11; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.